Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Øjenklinikken Hestetorvet ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   8.6% 7.6% 5.3% 9.5% 4.9% 4.8% 15.5% 15.5%   Credit score (0-100)   30 33 42 25 44 44 13 13   Credit rating   BB BB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,270 2,308 2,995 2,495 2,390 2,640 0.0 0.0   EBITDA   590 621 1,144 -26.2 -99.7 -99.4 0.0 0.0   EBIT   590 621 1,144 -26.2 -99.7 -186 0.0 0.0   Pre-tax profit (PTP)   589.2 599.0 1,122.7 -0.2 -55.7 33.7 0.0 0.0   Net earnings   459.5 466.8 875.7 -0.4 -45.0 26.1 0.0 0.0   Pre-tax profit without non-rec. items   589 599 1,123 -0.2 -55.7 33.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 690 0.0 0.0   Shareholders equity total   510 576 952 51.7 6.7 32.8 -17.2 -17.2   Interest-bearing liabilities   175 132 247 945 2,099 2,048 17.2 17.2   Balance sheet total (assets)   1,180 1,184 5,911 6,114 2,616 2,755 0.0 0.0   Net Debt   175 120 245 945 2,099 2,048 17.2 17.2     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,270 2,308 2,995 2,495 2,390 2,640 0.0 0.0   Gross profit growth   0.0% 1.7% 29.8% -16.7% -4.2% 10.5% -100.0% 0.0%   Employees   5 5 5 7 7 9 0 0   Employee growth %   0.0% 0.0% 0.0% 40.0% 0.0% 28.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,180 1,184 5,911 6,114 2,616 2,755 0 0   Balance sheet change%   0.0% 0.3% 399.4% 3.4% -57.2% 5.3% -100.0% 0.0%   Added value   590.3 621.5 1,143.9 -26.2 -99.7 -99.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 604 -690 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   26.0% 26.9% 38.2% -1.1% -4.2% -7.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   50.0% 52.6% 32.2% 2.1% 3.1% 2.6% 0.0% 0.0%   ROI %   86.3% 89.3% 119.9% 11.3% 8.7% 3.3% 0.0% 0.0%   ROE %   90.2% 86.0% 114.6% -0.1% -154.1% 132.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   43.2% 48.7% 16.1% 0.8% 0.3% 1.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   29.6% 19.3% 21.5% -3,599.0% -2,105.2% -2,059.7% 0.0% 0.0%   Gearing %   34.3% 22.9% 25.9% 1,827.5% 31,339.9% 6,252.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.3% 14.7% 11.2% 20.9% 12.6% 1.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.8 1.9 1.2 1.0 0.8 0.5 0.0 0.0   Current Ratio   1.8 1.9 1.2 1.0 0.8 0.5 0.0 0.0   Cash and cash equivalent   0.0 12.2 1.6 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   509.5 576.4 952.1 51.7 -593.3 -1,233.8 -8.6 -8.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   118 124 229 -4 -14 -11 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   118 124 229 -4 -14 -11 0 0   EBIT / employee   118 124 229 -4 -14 -21 0 0   Net earnings / employee   92 93 175 -0 -6 3 0 0